A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC

Trial Profile

A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs AAV-hAADC (Primary)
  • Indications Inborn error amino acid metabolic disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Oct 2017 Planned End Date changed from 1 Sep 2016 to 31 Dec 2020.
    • 18 Oct 2017 Planned primary completion date changed from 1 Oct 2015 to 31 Dec 2020.
    • 18 Oct 2017 Status changed from completed to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top